Green asymmetric synthesis of epoxypeptidomimetics and evaluation as human cathepsin K inhibitors
- PMID: 32631567
- DOI: 10.1016/j.bmc.2020.115597
Green asymmetric synthesis of epoxypeptidomimetics and evaluation as human cathepsin K inhibitors
Abstract
Cathepsin K (CatK) is a cysteine protease known for its potent collagenolytic activity, being recognized as an important target to the development of therapies for the treatment of bone disorders. Epoxypeptidomimetics have been reported as potent inhibitors of cathepsins, thus in this work we present a green synthesis of new peptidomimetics by using a one-pot asymmetric epoxidation/Ugi multicomponent reaction. The compounds were evaluated against CatK showing selectivity when compared with cathepsin L, with an inhibition profile in the low micromolar IC50 range. Investigation of the mechanism of action carried out for compounds LSPN428 and LSPN694 suggested a mixed inhibition mode and docking studies allowed a better understanding about interactions of inhibitors with the enzyme.
Keywords: Cathepsin K; Cysteine proteases; Inhibitors; Peptidomimetics.
Copyright © 2020 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
A composite docking approach for the identification and characterization of ectosteric inhibitors of cathepsin K.PLoS One. 2017 Oct 31;12(10):e0186869. doi: 10.1371/journal.pone.0186869. eCollection 2017. PLoS One. 2017. PMID: 29088253 Free PMC article.
-
Novel selective proline-based peptidomimetics for human cathepsin K inhibition.Bioorg Med Chem Lett. 2024 Sep 15;110:129887. doi: 10.1016/j.bmcl.2024.129887. Epub 2024 Jul 11. Bioorg Med Chem Lett. 2024. PMID: 39002936
-
An Activity-Based Probe for Cathepsin K Imaging with Excellent Potency and Selectivity.J Med Chem. 2021 Sep 23;64(18):13793-13806. doi: 10.1021/acs.jmedchem.1c01178. Epub 2021 Sep 2. J Med Chem. 2021. PMID: 34473502
-
Advances in the discovery of cathepsin K inhibitors on bone resorption.J Enzyme Inhib Med Chem. 2018 Dec;33(1):890-904. doi: 10.1080/14756366.2018.1465417. J Enzyme Inhib Med Chem. 2018. PMID: 29723068 Free PMC article. Review.
-
Peptidomimetic inhibitors of cathepsin K.Curr Top Med Chem. 2010;10(7):745-51. doi: 10.2174/156802610791113450. Curr Top Med Chem. 2010. PMID: 20337585 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources